Form 4: Quaker Chemical VP Frodl Receives 61 Restricted Stock Units

Andre Frodl, VP of R&D-Metals & Metalworking at Quaker Chemical Corp, was granted 61 restricted stock units, aligning his interests with shareholders.

Summary

• Andre Frodl, VP, R&D-Metals & Metalworking, acquired 61 Restricted Stock Units (RSUs) of Quaker Chemical Corp (KWR).
• The transaction date for the grant was October 15, 2025.
• Each RSU represents a contingent right to receive one share of KWR common stock.
• The RSUs will vest in three annual installments, commencing on March 15, 2026.
• Dividend equivalent rights will accrue on these RSUs when dividends are paid on KWR's common stock.
• Following this transaction, Andre Frodl directly beneficially owns 61 derivative securities (RSUs).

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a key executive is a positive development, aligning management's interests with shareholders and promoting long-term retention and performance. It's a routine, expected event, hence not a 'strong buy' signal, but certainly not negative.

Positives

• The grant of restricted stock units to a key executive, Andre Frodl, aligns his long-term interests with those of shareholders.
• The vesting schedule over three years encourages retention and sustained performance from a senior VP.
• Dividend equivalent rights provide additional incentive and tie executive compensation to shareholder returns.

Future Outlook

The vesting schedule for the restricted stock units, commencing March 15, 2026, indicates a long-term incentive structure designed to retain the executive and align future performance with shareholder value.

Industry Context

The grant of restricted stock units is a standard practice in executive compensation across various industries, including specialty chemicals, to attract, retain, and motivate key personnel by linking their compensation to the company's long-term stock performance.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) with a multi-year vesting schedule is a common and widely accepted form of long-term incentive compensation for senior executives in publicly traded companies, comparable to practices at peers like PPG Industries, Sherwin-Williams, or Ecolab.
• The grant size of 61 units for a VP-level executive is within typical ranges for supplemental equity grants, though specific comparisons would require detailed compensation benchmarks for similar roles and company sizes.
• The inclusion of dividend equivalent rights is also a standard feature of RSU plans, ensuring executives benefit from shareholder returns during the vesting period.

Stakeholder Impact

• Shareholders: The grant aligns the executive's financial interests with shareholder value creation over the long term.
• Employees: May signal stability in executive leadership and a commitment to long-term incentives.

Next Steps

• The restricted stock units will begin vesting in three annual installments starting March 15, 2026.
• Dividend equivalent rights will accrue and be paid when dividends are declared on KWR common stock.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of restricted stock units to a company executive, which is a standard component of executive compensation. While it positively aligns management's interests with shareholders, it does not present new material information that would fundamentally alter the investment thesis for Quaker Chemical Corp. Therefore, a 'hold' recommendation is appropriate, as this filing alone does not warrant a change in an existing investment position.

Keywords

Quaker Chemical, KWR, Andre Frodl, Restricted Stock Units, RSU, insider transaction, executive compensation, Form 4, equity grant